These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 17437804

  • 1. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
    Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Parnes HL, Lippman SM, Coltman CA.
    J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804
    [Abstract] [Full Text] [Related]

  • 2. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
    Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Natl Cancer Inst; 2006 Aug 16; 98(16):1128-33. PubMed ID: 16912265
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA.
    J Urol; 2007 Jul 16; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.
    J Urol; 2001 Oct 16; 166(4):1339-42. PubMed ID: 11547069
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM.
    J Urol; 2005 Sep 16; 174(3):877-81. PubMed ID: 16093979
    [Abstract] [Full Text] [Related]

  • 10. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM.
    J Urol; 2009 Feb 16; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [Abstract] [Full Text] [Related]

  • 11. The influence of prostate volume on prostate-specific antigen performance: implications for the prostate cancer prevention trial outcomes.
    Elliott CS, Shinghal R, Presti JC.
    Clin Cancer Res; 2009 Jul 15; 15(14):4694-9. PubMed ID: 19584168
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
    Marberger M, Freedland SJ, Andriole GL, Emberton M, Pettaway C, Montorsi F, Teloken C, Rittmaster RS, Somerville MC, Castro R.
    BJU Int; 2012 Apr 15; 109(8):1162-9. PubMed ID: 21699645
    [Abstract] [Full Text] [Related]

  • 13. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ.
    BJU Int; 2008 Sep 15; 102(8):969-74. PubMed ID: 18691175
    [Abstract] [Full Text] [Related]

  • 14. Is race a positive predictor of cancer on repeat prostate biopsy?
    Yanke BV, Salzhauer EW, Colon I.
    J Urol; 2006 Sep 15; 176(3):1114-7. PubMed ID: 16890704
    [Abstract] [Full Text] [Related]

  • 15. [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].
    Villers A.
    Prog Urol; 2008 Apr 15; 18 Suppl 3():S58-62. PubMed ID: 18455086
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.
    Elliott CS, Shinghal R, Presti JC.
    J Urol; 2008 May 15; 179(5):1756-61; discussion 1761. PubMed ID: 18343425
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.